(Q38817761)

6 September 2017

title

Sphingosine-1-Phosphate Signaling in Endothelial Disorders (English)

1 reference

6 September 2017

0 references

Teresa Sanchez

1

1 reference

6 September 2017

publication date

1 June 2016

1 reference

Current Atherosclerosis Reports

6 September 2017

published in

1 reference

6 September 2017

volume

18

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

31

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-016-0586-1

6 September 2017

exact match

0 references

cites work

Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Spatial and temporal dynamics of the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Antiedema therapy in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Barbiturate coma in severe hemispheric stroke: useful or obsolete?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Vascular endothelium as a contributor of plasma sphingosine 1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Differential roles of Edg-1 and Edg-5, sphingosine 1-phosphate receptors, in the signaling pathways in C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Essential role for sphingosine kinases in neural and vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

The immune modulator FTY720 targets sphingosine 1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

PTEN as an effector in the signaling of antimigratory G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine 1-phosphate activates Weibel-Palade body exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Tumor necrosis factor- induces adhesion molecule expression through the sphingosine kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Antiinflammatory properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Improving reperfusion therapy for acute ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Recanalization and reperfusion therapies for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Cerebral microvessel responses to focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Fingolimod provides long-term protection in rodent models of cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke-no influence on functional outcome and blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Impact of an immune modulator fingolimod on acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Oral fingolimod (FTY720) for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Stroke-induced immunodepression: experimental evidence and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0586-1

Cerebral ischemia. II. The no-reflow phenomenon

21 January 2018

1 reference

12 December 2020

Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells

1 reference

12 December 2020

Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets

1 reference

12 December 2020

Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice

1 reference

12 December 2020

Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction.

1 reference

12 December 2020

Endothelial cells in physiology and in the pathophysiology of vascular disorders

1 reference

12 December 2020

Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions

1 reference

12 December 2020

Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum

1 reference

12 December 2020

HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis

1 reference

12 December 2020

High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor

1 reference

12 December 2020

10.1007/S11883-016-0586-1

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1015675024

0 references

1 reference